Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active- and placebo-controlled study of clotrimazole vaginal tablets for vulvovaginal candidiasis
CTR20253876Phase 3Active
- Sponsor
- Gaozhi Pharma
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clotrimazole in vulvovaginal candidiasis (VVC), sponsored by Gaozhi Pharma. Started Oct 2025; status: active.
02
Drugs
clotrimazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on CTR20253876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253876.